AlphaYouBB
Insider selling
Blake Borgeson sold $100K of Recursion Pharmaceuticals, Inc. (RXRX) stock
Blake Borgeson, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 30,000 shares of RXRX stock worth $100K, per an SEC Form 4 filed Sep 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 1 day before it was made public.
RXRX has moved +21.6% since the trade date, from $3.33 to $4.05 (Sep 22, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 2, 2026
- Filing delay
- 1 day
- Price since
- +21.6%
- Role
- Dir
- Source
- SEC Form 4
More RXRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.